Pyxis Oncology (PYXS) Interest & Investment Income (2020 - 2025)
Pyxis Oncology's (PYXS) quarterly Interest & Investment Income came in at -$50000.0 in Q4 2025, down 107.25% year-on-year from $690000.0 in Q4 2024, and down 109.4% on a QoQ basis from $532000.0 in Q3 2025.
Pyxis Oncology (PYXS) Interest & Investment Income (2020 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has 6 years of Interest & Investment Income data on file, last reported at -$50000.0 in Q4 2025.
- On a quarterly basis, Interest & Investment Income fell 107.25% year-over-year to -$50000.0 in Q4 2025; TTM through Dec 2025 was $2.6 million, a 56.91% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 51.55% from the prior year.
- Interest & Investment Income for Q4 2025 stood at -$50000.0, down from $532000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for PYXS reached as high as $2.0 million in Q2 2024 and fell as low as -$1.5 million in Q4 2023.
- Historically, Interest & Investment Income has averaged $668800.0 across 5 years, with a median of $648500.0 in 2023.
- Across the five-year window, Interest & Investment Income jumped 26642.86% in 2022 and tumbled 180.4% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at $7000.0 in 2021, then soared by 26642.86% to $1.9 million in 2022, then tumbled by 180.4% to -$1.5 million in 2023, then surged by 145.85% to $690000.0 in 2024, then tumbled by 107.25% to -$50000.0 in 2025.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$50000.0 in Q4 2025, $532000.0 in Q3 2025, and $995000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Pyxis Oncology | 182.39 Mn | 115.53 Mn | 8.65 Mn | -50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -50,000.00 |
| Sep 30, 2025 | 532,000.00 |
| Jun 30, 2025 | 995,000.00 |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 690,000.00 |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 2.02 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | -1.51 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 607,000.00 |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 719,000.00 |
| Jun 30, 2022 | 164,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 4,000.00 |